DrugPatentWatch Database Preview

AFREZZA Drug Profile

Email this page to a colleague

« Back to Dashboard

Summary for Tradename: AFREZZA

Patents:	31
Applicants:	1
BLAs:	1
Suppliers: see list	1
Drug Prices:	Drug price information for AFREZZA
Recent Clinical Trials:	See clinical trials for AFREZZA
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for AFREZZA

See drug prices for AFREZZA

Recent Clinical Trials for AFREZZA

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Diabetes and Glandular Disease Clinic	Phase 4
DexCom, Inc.	Phase 4
Yale University	Phase 1

See all AFREZZA clinical trials

Recent Litigation for AFREZZA

Identify key patents and potential future biosimilar entrants

PTAB Litigation

Petitioner	Date
	2014-06-16

See all AFREZZA litigation

Patent Text Search: US Patents for AFREZZA

These patents were identified by searching patent claims

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Mannkind	AFREZZA	insulin recombinant human	POWDER;INHALATION	022472	001	2014-06-27		SDG, Inc. (Cleveland, OH)	2025-05-23	RX		search
Mannkind	AFREZZA	insulin recombinant human	POWDER;INHALATION	022472	001	2014-06-27		SDG, Inc. (Cleveland, OH)	2025-05-23	RX		search
Mannkind	AFREZZA	insulin recombinant human	POWDER;INHALATION	022472	001	2014-06-27		INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (Beijing, CN)	2030-07-14	RX		search
Mannkind	AFREZZA	insulin recombinant human	POWDER;INHALATION	022472	001	2014-06-27		INDIAN INSTITUTE OF TECHNOLOGY, BOMBAY (Mumbai, IN)	2036-02-19	RX		search
Mannkind	AFREZZA	insulin recombinant human	POWDER;INHALATION	022472	001	2014-06-27		MannKind Corporation (Westlake Village, CA)	2028-08-11	RX		search

International Patents for AFREZZA

Country	Patent Number	Estimated Expiration
Uruguay	35231
Taiwan	201625669
European Patent Office	3207942
Israel	238623
Japan	2003503387